Pfizer, Johnson & Johnson Yet to Apply for EUA for Covid-19 Vaccines in India
US pharma major Pfizer and Johnson & Johnson (J&J) are yet to seek Emergency Use Authorization or EUA for their […]
Govts must scale-up better TB treatment as J&J slashes drug price
The pharmaceutical corporation Johnson & Johnson (J&J) has announced a reduced price of US$1.50* per day for the tuberculosis (TB) […]
Experts deliberate on innovative practices to bolster patient care
In an endeavour to deliberate upon various aspects of the healthcare delivery system, especially accessibility, affordability and cost-efficiency, the Healthcare […]
CDSCO confirms absence of formaldehyde in J&J baby shampoo
The Central Drugs Standard Control Organisation on Monday has strongly confirmed the validity of Johnson & Johnson’s baby shampoo stating […]
Johnson & Johnson to pay Rs 75 lakh in faulty hip implant case
Johnson and Johnson Pvt. Ltd has been ordered to pay Rs 74.6 lakh to an unidentified Mumbai-based patient. The order […]
Moody’s affirms J&J’s Aaa rating
Moody’s Investors Service affirmed the ratings of Johnson & Johnson including the Aaa senior unsecured rating and the Prime-1 commercial […]
Johnson & Johnson accepts offer of US$ 1.94 Billion from Cardinal Health
Johnson & Johnson has accepted the offer of US$ 1.94 billion from Cardinal Health to acquire its Cordis business.Accepted after […]
